• Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

  • Nov 19 2024
  • Length: 57 mins
  • Podcast

Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Listen for free

View show details

  • Summary

  • Featuring perspectives from Dr Komal Jhaveri and Dr Hope S Rugo, including the following topics:

    • Introduction: PI3K/AKT/PTEN Pathway and Resistance to Endocrine Therapy (0:00)
    • First-Line Therapy for HR-Positive Metastatic Breast Cancer (mBC) Harboring PI3K/AKT/PTEN Mutations (7:04)
    • Treatment Options for Recurrent mBC with PI3K/AKT/PTEN Mutations (24:11)
    • Beyond the Guidelines Survey (35:36)
    • Faculty Case Presentations (51:27)

    CME information and select publications
    Show More Show Less
Show More Show Less

What listeners say about Hormone Receptor-Positive Metastatic Breast Cancer | Optimizing Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer Harboring PI3K/AKT/PTEN Pathway Abnormalities

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.